Web Analytics




Home Tags Posts tagged with "Yisheng Biopharma"

Tag: Yisheng Biopharma

Deal digest

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Correspondents

SEC and the cost of local capital market investment

SEC and the cost of local capital market investment

By Luke Morgan B Codilla, ACCRALAW
Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now